Skip to content

Combined monitoring of thromboelastography, coagulation function and mean platelet volume/platelet count ratio (MPV/PC ratio) to evaluate the prognosis of patients with sepsis

Combined monitoring of thromboelastography, coagulation function and mean platelet volume/platelet count ratio (MPV/PC ratio) to evaluate the prognosis of patients with sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052736
Enrollment
Unknown
Registered
2021-11-04
Start date
2021-11-15
Completion date
Unknown
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The patient meets the diagnostic criteria for sepsis at the 2016 International Sepsis Conference; 2. Aged >= 18 years; 3. Complete the treatment process according to the guidelines recommended.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors, primary heart, lung, liver, kidney and other organ dysfunction; 2. Patients with autoimmune diseases, coagulation factor deficiency, systemic lupus erythematosus, acute cardiovascular and cerebrovascular diseases, anemia caused by genetic factors, primary and secondary thrombocytosis or reduction; 3. Recent blood transfusion, taking anticoagulant, antiplatelet and other drugs; 4. Those with incomplete case data; 5. Those who give up treatment in the middle; 6. Follow-up failures.

Design outcomes

Primary

MeasureTime frame
Thromboelastogram;Coagulation function;Mean platelet volume / platelet count ratio;

Countries

China

Contacts

Public ContactYan Xianliang

Affiliated Hospital of Xuzhou Medical University

docyxl@163.com+86 18052268393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026